Apotex Health Corp (APTX)

Apotex Health Corp experienced three significant insider trading transactions on September 18, 2026, totaling 850 million CAD in sales. Major shareholders, including SK Artemis Holdings II and API Investment LP, alongside director Allan Grant Oberman, divested substantial equity positions. These disposals occurred amidst a 10.3% stock price increase over the preceding ninety-day period.
Ticker: APTX Exchange: TOR


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
SK Artemis Holdings II, LLC 10% Security Holder of Issuer Large shareholder
Transaction date
Sale
Price
111.58
Quantity 560 -44.7%
Value CA$4,813,103
Oberman, Allan Grant Director of Issuer Non-Executive Director
Transaction date
Sale
Price
387.16
Quantity 90,646
Value CA$2,201,064
API Investment LP 10% Security Holder of Issuer Large shareholder
Transaction date
Sale
Price
245.74
Quantity 46,481 -22.2%
Value CA$4,213,370
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-09-18 2026-09-18 S Sale

10% Security Holder of Issuer

Large shareholder
560 -44.7%
111.58
CA$4,813,103
560 -44.7% 111.58 CA$4,813,103
2026-09-18 2026-09-18 S Sale

Director of Issuer

Non-Executive Director
90,646
387.16
CA$2,201,064
90,646 387.16 CA$2,201,064
2026-09-18 2026-09-18 S Sale

10% Security Holder of Issuer

Large shareholder
46,481 -22.2%
245.74
CA$4,213,370
46,481 -22.2% 245.74 CA$4,213,370